| Title |
The Duality of Economic Issues With Medication Non-adherence in Patients With Inflammatory Arthritis
|
|---|---|
| Published in |
Current Rheumatology Reports, September 2017
|
| DOI | 10.1007/s11926-017-0691-3 |
| Pubmed ID | |
| Authors |
Natasha K. J. Campbell, Khalid Saadeldin, Mary A. De Vera |
| Abstract |
In this review, we synthesize current data on non-adherence across inflammatory arthritides and explore (1) the effects of economic factors on non-adherence and (2) the impacts of non-adherence on economic outcomes. Recent evidence demonstrates medication non-adherence rates as high as 74% in ankylosing spondylitis (AS), 90% in gout, 50% in psoriatic arthritis (PsA), 75% in systemic lupus erythematosus (SLE), and 82% in rheumatoid arthritis (RA). The effects of socioeconomic factors have been studied most in RA and SLE but with inconsistent findings. Nonetheless, the evidence points to having prescription coverage and costs of treatment as important factors in RA and education as an important factor in SLE. Limited data in AS and gout, and no studies of the effects of socioeconomic factors in PsA, show knowledge gaps for future research. Finally, there is a dearth of data with respect to the impacts of non-adherence on economic outcomes. |
X Demographics
The data shown below were collected from the profiles of 28 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 11 | 39% |
| Philippines | 1 | 4% |
| Ireland | 1 | 4% |
| Australia | 1 | 4% |
| Netherlands | 1 | 4% |
| United Kingdom | 1 | 4% |
| Canada | 1 | 4% |
| India | 1 | 4% |
| Argentina | 1 | 4% |
| Other | 1 | 4% |
| Unknown | 8 | 29% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 19 | 68% |
| Practitioners (doctors, other healthcare professionals) | 6 | 21% |
| Science communicators (journalists, bloggers, editors) | 3 | 11% |
Mendeley readers
The data shown below were compiled from readership statistics for 38 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 38 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 9 | 24% |
| Researcher | 5 | 13% |
| Student > Bachelor | 5 | 13% |
| Student > Postgraduate | 4 | 11% |
| Student > Master | 4 | 11% |
| Other | 6 | 16% |
| Unknown | 5 | 13% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 13 | 34% |
| Pharmacology, Toxicology and Pharmaceutical Science | 7 | 18% |
| Agricultural and Biological Sciences | 3 | 8% |
| Nursing and Health Professions | 2 | 5% |
| Social Sciences | 2 | 5% |
| Other | 5 | 13% |
| Unknown | 6 | 16% |
Attention Score in Context
This research output has an Altmetric Attention Score of 19. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 September 2017.
All research outputs
#1,977,106
of 25,931,626 outputs
Outputs from Current Rheumatology Reports
#58
of 769 outputs
Outputs of similar age
#36,629
of 328,922 outputs
Outputs of similar age from Current Rheumatology Reports
#3
of 13 outputs
Altmetric has tracked 25,931,626 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 769 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.1. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 328,922 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 13 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.